Trial Profile

A Phase 3 clinical trial evaluating LB1148 in China

Status: Recruiting

Phase of Trial: Phase III

Latest Information Update: 07 Apr 2023

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Tranexamic acid (Primary)
Indications Postoperative ileus
Focus Therapeutic Use
Sponsors Newsoara Biopharma

Most Recent Events

07 Apr 2023 New trial record
05 Apr 2023 According to a Palisade Bio media release, company plans to advance toward successful completion of the study and data readout. We look forward to potentially bringing LB1148 to patients to improve post-operative outcomes by accelerating postoperative return of GI function and reducing post-surgical adhesions
05 Apr 2023 According to a Palisade Bio media release, this trial is being fully conducted and funded by Newsoara

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com